Over the last decade, capacity for influenza surveillance and research in West Africa has strengthened. Data from these surveillance systems showed influenza A(H1N1)pdm09 circulated in West Africa later than in other regions of the continent. We contacted 11 West African countries to collect information about their influenza surveillance systems (number of sites, type of surveillance, sampling strategy, populations sampled, case definitions used, number of specimens collected and number of specimens positive for influenza viruses) for the time period January 2010 through December 2012. Of the 11 countries contacted, 8 responded: Burkina Faso, Cote d’Ivoire, Mali, Mauritania, Niger, Nigeria, Sierra Leone and Togo. Countries used standard World Health Organization (WHO) case definitions for influenza-like illness (ILI) and severe acute respiratory illness (SARI) or slight variations thereof. There were 70 surveillance sites: 26 SARI and 44 ILI. Seven countries conducted SARI surveillance and collected 3114 specimens of which 209 (7%) were positive for influenza viruses. Among influenza-positive SARI patients, 132 (63%) were influenza A [68 influenza A(H1N1)pdm09, 64 influenza A(H3N2)] and 77 (37%) were influenza B. All eight countries conducted ILI surveillance and collected 20,375 specimens, of which 2278 (11%) were positive for influenza viruses. Among influenza-positive ILI patients, 1431 (63%) were influenza A [820 influenza A(H1N1)pdm09, 611 influenza A(H3N2)] and 847 (37%) were influenza B. A majority of SARI and ILI case-patients who tested positive for influenza (72% SARI and 59% ILI) were children aged 0–4 years, as were a majority of those enrolled in surveillance. The seasonality of influenza and the predominant influenza type or subtype varied by country and year. Influenza A(H1N1)pdm09 continued to circulate in West Africa along with influenza A(H3N2) and influenza B during 2010–2012. Although ILI surveillance systems produced a robust number of samples during the study period, more could be done to strengthen surveillance among hospitalized SARI case-patients. Surveillance systems captured young children but lacked data on adults and the elderly. More data on risk groups for severe influenza in West Africa are needed to help shape influenza prevention and clinical management policies and guidelines.
The presence of alphaviruses, such as chikungunya virus (CHIKV), has never been reported in Mauritania. We assessed the seroprevalence of CHIKV among Nouakchott residents. A cross-sectional study involving 1300 non-febrile patients consulting at the Nouakchott hospital center was conducted between January and June 2021. The presence of anti-CHIKV IgG and neutralizing antibodies against CHIKV, O’nyong-nyong virus (ONNV), and Semliki Forest virus (SFV) was determined by an enzyme-linked immunosorbent assay (ELISA) and a serum neutralization test, respectively, and the associated risk factors were investigated. Of the 1300 study participants, serological evidence of previous exposure to CHIKV was observed in 37 individuals (2.8%). Sex, age, reported use of repellants, and bed net ownership and usage were not associated with CHIKV seropositivity. Our results showed the co-circulation of two other alphaviruses, ONNV and SFV, in Nouakchott in 30 (2.3%) individuals. This is the first study that documents the co-circulation of CHIKV, ONNV, and SFV in Mauritania, albeit at low prevalence. Surveillance and routine testing for alphaviruses and other arboviruses in symptomatic patients should be implemented in health facilities to assess the health burden associated with these viruses. Efforts should also be made to strengthen the vector control measures.
The rapid genetic evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the coronavirus disease 2019 (COVID-19) pandemic has greatly challenged public health authorities worldwide, including in Mauritania. Despite the presence of the virus in Mauritania, only one study described its genomic variation during the course of the epidemic. The purpose of the present study was to document the genomic pattern of SARS-CoV-2 variants from clinical isolates during the COVID-19 outbreak in Mauritania, from September to November 2021. The whole genomes from 54 SARS-CoV-2 strains detected in nasopharyngeal swabs with a cycle threshold value ≤ 30 were successfully sequenced using next-generation sequencing (NGS) and the Illumina protocol. The mean genome coverage (±standard deviation) was 96.8% (±3.7). The most commonly identified clade was 21J (57.4%), followed by 21D (16.7%), 20A (11.1%), and 20B (9.2%). At the level of lineages, the majority of the samples were Delta variants with the sub-lineage AY.34 (or B.1.617.2.34). Among the 54 SARS-CoV-2 isolates that were successfully sequenced, 33 (61.1%) came from vaccinated individuals, and 21 (38.9%) were from unvaccinated individuals. Several SARS-CoV-2 variants were present in Mauritania between September and November 2021. As Mauritania, like many West African countries, is resource-limited regarding viral genome sequencing facilities, establishment of mutualized sub-regional sequencing platforms will be necessary to ensure continuous monitoring of mutations in viral genomes and track potential reduction in COVID-19 vaccine efficacy, increased transmissibility, and disease severity.
La surveillance des fièvres hémorragiques virales en Mauritanie fait partie de la Surveillance intégrée des maladies et riposte (SIMR). Peu d’informations sont disponibles sur l’évaluation du système de surveillance des fièvres hémorragiques virales dans la wilaya (région) de l’Assaba en Mauritanie. Une étude transversale descriptive a été menée de juillet à août 2022 dans la wilaya de l’Assaba avec comme objectif d’évaluer les caractéristiques du système en interrogeant tous les acteurs impliqués dans la surveillance des fièvres hémorragiques virales dans la wilaya de l’Assaba, en mettant l’accent sur la fièvre de la Vallée du Rift et la fièvre hémorragique de Crimée-Congo à l’aide des questionnaires élaborés sur la base des directives des Centers for Disease Control and Prevention. La base de données de 2020-2022 des fièvres hémorragiques virales du laboratoire de l’Institut national de recherche en santé publique a été analysée. Les médianes, les intervalles interquartiles et les proportions ont été calculés à l’aide des logiciels Epi Info® 7.2.5.0 et Excel® 2021. L’entretien a concerné 26 acteurs impliqués dans le système de surveillance des fièvres hémorragiques virales. La majorité des répondants de l’enquête ont trouvé le système utile (51 %), simple (63 %), acceptable (46 %), réactif (64 %) et flexible (46 %). Selon l’analyse de la base de données de l’Institut national de recherche en santé publique, les cas de fièvres hémorragiques virales ont été pris en charge rapidement. Les réponses à l’enquête et l’analyse de la base de données ont révélé l’existence de problèmes sur le plan de la qualité des données et des mécanismes de gestion des données. Le système de surveillance des fièvres hémorragiques virales dans la wilaya de l’Assaba est fidèle à l’organisation et au fonctionnement du système national de surveillance des fièvres hémorragiques virales qui fait partie de la SIMR. Les caractéristiques d’utilité, de simplicité, de réactivité et de flexibilité du système de surveillance des fièvres hémorragiques virales sont satisfaisantes, mais l’acceptabilité et la flexibilité doivent être améliorées.